If you would like to be alerted when a presentation is added to this site, please register with the
Alerting Service.
| May, 2010 |
Corporate Presentation |
 |
| Aug 5, 2010 |
Second Quarter 2010 Financial Results |
 |
| May 17, 2010 |
Rodman & Renshaw Annual Global Investment Conference |
 |
| May 13, 2010 |
First Quarter 2010 Financial Results |
 |
| Mar 23, 2010 |
Fourth Quarter 2009 Financial Results |
 |
| Mar 15, 2010 |
ROTH Capital OC Growth Stock Conference |
 |
| Feb 8, 2010 |
BIO & CEO Conference |
 |
| Jan 13, 2010 |
OneMedForum 2010 Finance Conference |
 |
| Dec 7, 2009 |
Review of Phase 2 Sapacitabine Data to be presented at ASH |
 |
| Dec 1, 2009 |
New York Society of Security Analysts' 13th Annual NYSSA Biotech & Specialty Pharmaceuticals Industry Conference |
 |
| Nov 17, 2009 |
Lazard Capital Markets 6th Annual Healthcare Conference |
 |
| Nov 10, 2009 |
Merriman Investor Summit 2009 |
 |
| Nov 3, 2009 |
Third Quarter 2009 Financial Results |
 |
| Oct 29, 2009 |
8th Annual BIO Investor Forum |
 |
| Sept 10, 2009 |
Rodman & Renshaw 11th Annual Healthcare Conference |
 |
| Aug 6, 2009 |
Second Quarter 2009 Financial Results |
 |
| Jun 10, 2009 |
Needham & Company, LLC Biotechnology & Medical Technology Conference |
 |
| Jun 3, 2009 |
Report Phase 2 Sapacitabine Data in Patients with Advance Leukemias and Myelodysplastic Syndromes |
 |
| May 14, 2009 |
First Quarter 2009 Financial Results |
 |
| Mar 31, 2009 |
Fourth Quarter 2008 Financial Results |
 |
| Feb 9, 2009 |
BIO CEO & Investor Conference |
 |